| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.049 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |